DKDiomidis Kozyrakis

Diomidis Kozyrakis

*This is an algorithmically generated author record based on publicly available information.

Diomidis Kozyrakis has a total of 100 co-authors. Here are the top co-authors by number of shared publications:

  • Anastasios Zarkadas

    Department of Urology, Konstantopouleio-Patision General Hospital of Nea Ionia, Nea Ionia, Athens, Greece

    7 shared publications
  • Athanasios Filios

    Department of Urology, Konstantopouleio-Patision General Hospital of Nea Ionia, Nea Ionia, Athens, Greece

    4 shared publications
  • Dimitrios Bozios

    Department of Urology, Konstantopouleio-Patision General Hospital of Nea Ionia, Nea Ionia, Athens, Greece

    4 shared publications
  • Dimitrios Bozios

    Department of Urology, Konstantopouleion–Patision Hospital, N. Ionia, 14233 Attika, Greece

    4 shared publications
  • Evangelos Rodinos

    Department of Urology, Konstantopouleion–Patision Hospital, N. Ionia, 14233 Attika, Greece

    4 shared publications
  • Georgios Kallinikas

    Department of Urology, Konstantopouleio-Patision General Hospital of Nea Ionia, Nea Ionia, Athens, Greece

    4 shared publications

Latest Publications

  • Open Access

    A Brief Review of MicroRNA Profiling in Human Prostate Cancer Tissues and Plasma

    by Georgios Kallinikas, Amin M. Ektesabi, Chirag M. Vaswani, Georgios Haronis, Eirini Kallinika, Diomidis Kozyrakis, Evangelos Rodinos, Athanasios Filios, Panagiotis Filios, Despoina Mityliniou, et al.

    (1) Background: The gold standard, prostate-specific antigen (PSA) screening lacks the sensitivity and specificity required for confident, early prostate-cancer detection. MicroRNAs (miRNAs) are small, highly stable, non-coding RNAs whose expression changes reproducibly in malignancy and therefore offer promise as minimally invasive biomarkers. Although prostate cancer biopsies are the gold standard for prostate cancer diagnosis, limitations in the field continue to persist. Since circulating fluids can also be a source of miRNA biomarkers, we investigated the overlap between miRNAs enriched in prostate cancer tissue and those isolated from the plasma of patients with prostate cancer. (2) Methods: We synthesized the published literature (PubMed, Google Scholar, ResearchGate, 2005–April 2025) and re-analyzed three Gene Expression Omnibus (GEO) datasets (GSE54516, GSE21032—tissue; GSE206793—plasma) to identify miRNAs consistently dysregulated in prostate cancer tissue and circulation. (3) Results: Of the 318 screened full-text articles, 24 met the inclusion criteria. From the GEO reanalysis (false-discovery-rate < 0.05, |log2FC| ≥ 1), 219 and 326 miRNAs were differentially expressed in tissue, whereas 12 were altered in plasma. Two miRNAs—miR-449b and miR-455-3p—were common in both compartments, highlighting their translational potential as liquid biopsy surrogates of tumor biology. (4) Conclusions: We summarize functional evidence for leading tumor-suppressive (e.g., miR-205, miR-23b, miR-455-3p) and oncogenic (e.g., miR-21, miR-182, miR-449b) candidates, discuss their intersection with the androgen-receptor, TGF-β, WNT/β-catenin, and PI3K-AKT signaling, and outline outstanding requirements for the clinical qualification of miRNA panels in prostate cancer.


  • Comparison of Robot-Assisted Versus Open Partial Nephrectomy for Treating Renal Malignancies With An Emphasis on Oncological Outcomes: A Systematic Review and Meta-Analysis of The Literature

    by Diomidis Kozyrakis, Chara Tzavara, Christos Damaskos, Anastasios Zarkadas, Dimitrios Bozios, Athanasios Karmogiannis, Vasileios Konstantinopoulos, Georgios Haronis, Anna-Maria Konomi, Georgios Kallinikas, et al.

    Robotic assisted partial nephrectomy (RaPN) is the treatment of choice for small and resectable renal tumors offering better results in terms of blood loss, postoperative complications and length of hospital stay compared with the open partial nephrectomy (OPN), while for both techniques the risk of postoperative renal dysfunction is limited. However, the oncologic outcomes of the robotic procedure are yet to be determined. Therefore, a comprehensive research of PubMed/Medline, Embase and Scopus databases from the year 2000 till June 2024 was performed to elucidate the results related to oncologic outcomes. The ROBINS-I tool for non-randomized cohort studies was applied for the assessment of the quality of the included studies. All statistical analyses were performed with the use of STATA software version 15.0. The study was registered in International Platform of Registered Systematic Review and Metaanalysis Protocols database with the registration number INPLASY202450054. Overall 11 studies with 4758 patients were included in the present systematic review and meta-analysis. No statistically significant difference between the two treatment methods was reconded for the outcomes of overall survival [HR: 1.23 (95% CI: 0.68, 2.20)- p = 0.488], disease-specific survival [OR: 2.53 (95% CI: 0.65, 9.78)- p = 0.179], progression-free survival [HR: 1.04 (95% CI: 0.60, 1.79)- p = 0.901], recurrence-free survival [HR: 0.83 (95% CI = 0.54, 1.27)-p = 0.394] and disease-free survival [OR: 1.01 (95% CI = 0.98, 1.03)-p = 0.582]. The quality of most of the included studies was deemed moderate. Despite the need for more high quality comparative studies it is assumed that these results could be helpful in decision making and in counselling patients with resectable renal tumors to whom a nephron sparing surgery may be considered.


  • Open Access

    Prostate artery embolization as an effective treatment for clinically significant prostate cancer‑related hemorrhage: A case report

    by Diomidis Kozyrakis, Vasilios Konstantinopoulos, Panagiotis Papaspyridakos, Anastasios Zarkadas, Dimitrios Bozios, Athanasios Karmogiannis, Georgios Haronis, Anna-Maria Konomi, Georgios Kallinikas, Konstantinos Safioleas, et al.

    A 79‑year old Caucasian male with metastatic hormone refractory prostate cancer and bilateral nephrostomy was admitted to the emergency department due to 4‑day bloody urethral discharge, weakness and dizziness. The patient was treated with the luteinizing hormone‑releasing hormone‑antagonist and abiraterone acetate plus prednisone, dabigatran 150 mg bid (for atrial fibrillation and coronary heart disease) and 5‑aminosalicylic acid for the management of mild ulcerative colitis. Imaging revealed bladder overdistention and blood analysis low levels of hematocrit (HCT) and hemoglobin (HGB) (HCT, 22%; HGB, 7.1 gr/dl). A 22F, 3‑way urethral catheter was placed, and blood clots were removed with a syringe. Continuous normal saline irrigation was initiated, and the dabigatran was withdrawn; however, no evidence of control of blood loss was shown. Computed tomography and urography revealed a large prostate lesion invading the bladder neck, a pelvic lymph‑node block and lack of blood extravasation. Diagnostic urethrocystoscopy revealed diffuse hematuria from the prostate lesion and bladder neck. Bipolar coagulation was performed in the absence of any significant improvement. Upon withdrawal of intravesical irrigation, the oral consumption of a large water volume (a useful measure to control hematuria and avoid clot formation) could not be applied to the patient due to urine storage and normal voiding being not feasible. Subsequently, the patient was informed on the option of superselective arterial embolization (SAE). Following signing of the relevant consent form, the patient underwent bilateral SAE of prostatic and inferior cystic arteries, while he was in heparin delivery. Dabigatran was re‑administered on the 5th postprocedural day and the catheter was removed following 5 days. Following a 4‑month follow‑up, the patient's condition was stable with no traceable hematuria. In conclusion, the minimal invasiveness of SAE is an attractive option, notably in patients with cardiovascular comorbidities. It appears to be a safe alternative with an acceptable rate of minor complications. The encouraging results and the survival outcomes warrant further evaluation with comparative prospective multicenter studies.


  • Open Access

    A Brief Overview of Cholinergic and Phosphodiesterase-5 Inhibitors in Diabetic Bladder Dysfunction

    by Georgios Kallinikas, Georgios Haronis, Eirini Kallinika, Diomidis Kozyrakis, Evangelos Rodinos, Athanasios Filios, Panagiotis Filios, Despoina Mityliniou, Konstantinos Safioleas, Anastasios Zarkadas, et al.

    Diabetic bladder dysfunction (DBD) comprises a wide spectrum of lower urinary tract symptoms that impact diabetic patients’ lives, including urinary frequency, urgency, incontinence, and incomplete bladder emptying. To relieve symptoms, anticholinergics have been widely prescribed and are considered an effective treatment. There is increasing evidence that diabetic patients may benefit from the use of phosphodiesterase 5 (PDE5) inhibitors. This narrative review aims to provide a brief overview of the pathophysiology of DBD along with a focus on cholinergic and phosphodiesterase inhibitors as therapies that benefit DBD. An examination of the literature suggests compelling avenues of research and underscores critical gaps in understanding the mechanisms underlying DBD. New tools and models, especially rodent models, are required to further elucidate the mechanisms of action of current therapies in the treatment of DBS.


  • Survival outcomes after robot-assisted versus open partial nephrectomy for resectable renal tumors: A systematic review of the literature and meta-analysis.

    by Diomidis Kozyrakis, Tzavara Chara, Anastasios Zarkada, Dimitrios Bozios, Athanasios Karmogiannis, Vasileios Konstantinopoulos, Georgios Charonis, Anna-Maria Konomi, Georgios Kallinikas, Athanasios Filios, et al.

    INPLASY202450054 Survival outcomes after robot-assisted versus open partial nephrectomy for resectable renal tumors: A systematic review of the literature and meta-analysis. Keywords: Renal, Cancer…

  • Open Access

    Renal artery infarction in the SARS-Cov-2 era: A systematic review of case reports

    by Diomidis Kozyrakis, Georgios Kallinikas, Anastasios Zarkadas, Dimitris Bozios, Vasileios Konstantinopoulos, Georgios Charonis, Konstantinos Safioleas, Athanasios Filios, Evangelos Rodinos, Despoina Mytiliniou, et al.

    Aim: Renal artery infarction (RI) is the presence of blood clot in the main renal artery or its branches causing complete or partial obstruction of the blood supply. Its etiology is either related with disorders of the renal vasculature or with cardiovascular diseases. Recently, the SARSCoV- 2 virus is an emerging cause of thromboembolic events and the incidence of RI is anticipated to increase after the pandemic. Methods: A systematic review based on COVID-19 associated RI was conducted. Protocol: A systematic review of the Medline/Pubmed and Scopus databases was conducted in accordance to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (the PRISMA statement). Search strategy and information sources: A hand-search was performed using the terms “SARS-Cov-2” OR “COVID-19” AND “renal thrombosis” OR “renal infarction” OR “renal “thromboembolism”. Eligibility criteria: all types of publications (case reports, case series, letters to the editor, short communications) were evaluated for relevance. Inclusion criteria were: confirmed SARS-Cov-2 infection irrespectively of the age, diagnosis of RI during or after the onset of viral infection, and exclusion of other potential causes of thromboembolic event except of SARS-Cov-2. Patients with renal transplantation were also considered. Study criteria selection: after checking for relevance based on the title and the abstract, the full texts of the selected papers were retrieved and were further evaluated. Duplicated and irrelevant cases were excluded. Any disagreement was resolved by consensus with the involvement of a third reviewer. Quality of studies: The assessment of the quality case reports was based on four different domains: selection, ascertainment, casualty and reporting. Each paper was classified as “Good”, “Moderate” and “Poor” for any of the four domains. Data extractions: Crucial data for the conduct of the study were extracted including: age, sex, time from SARS-Cov-2 infection till RI development, medical history, previous or current antithrombotic protection or treatment, laterality and degree of obstruction, other sites of thromboembolism, treatment for thromboembolism and SARS-Cov-2 and final outcome. Data analysis: methods of descriptive statistics were implicated for analysis and presentation of the data. Results: The systematic review retrieved 35 cases in 33 reports. In most cases, RI was diagnosed within a month from the SARSCov- 2 infection albeit 17 out of 35 patients were receiving or had recently received thromboprophylaxis. Right, left, bilateral and allograft obstruction was diagnosed in 7, 15, 8 and 5 patients respectively. 17 cases experienced additional extrarenal thromboembolism primarily in aorta, spleen, brain and lower limbs. Low molecular weight heparins (LMWH) (usually 60-80 mg enoxaparine bid) was the primary treatment, followed by combinations of unfractionated heparin and salicylic acid, apixaban and rivaraxaban, warfarin, acenocoumarol or clopidogrel. Kidney replacement therapy was offered to five patients while invasive therapies with thrombus aspiration or catheter directed thrombolysis were performed in two. Regarding the outcomes, five of the patients died. The total renal function was preserved in 17 cases and renal impairment with or without hemodialysis was recorded in 5 patients, two of them having lost their kidney allografts. Limitations: The majority of included studies are of moderate quality. The results and the conclusions are based on case-reports only and crucial data are dissimilarly presented or missing through the relevant publications. Conclusions: Thromboprophylaxis may not offer adequate protection against SARS-Cov-2 induced thrombosis. Most patients could be effectively treated with conservative measures, while in more severe cases aggressive treatment could be recommended. Implications of key findings: Therapeutic doses of LMWH could be considered for protection against RI in SARS-Cov-2 cases. Interventional treatment could be offered in a minority of more severe cases after carful balancing the risks and benefits.


  • Open Access

    Management of Fournier's Gangrene in a COVID-19 Patient: Challenges and Dilemmas

    by Diomidis Kozyrakis, Dimitrios Bozios, Anastasios Zarkadas, Georgios Kallinikas, Gerasimos Vlassopoulos

    Fournier’s gangrene is a urologic emergency manifested as an aggressive form of necrotizing fasciitis. Co-infection of Fournier’s gangrene with COVID-19 might have catastrophic sequelae. We report a case of a 69-year-old male patient, unvaccinated against coronavirus, was obese, and with type 2 diabetes diagnosed with Fournier’s gangrene. Apart from administration of piperacillin/tazobactam and clindamycin, the patient underwent surgical debridement four hours after his presentation. Postoperatively, the PCR test for COVID-19 was proved to be positive. The patients develop septic shock necessitating the delivery of dopamine, supplemental oxygen, and thromboprophylaxis. On the seventh postoperative day, left testicular ischemia was developed and ipsilateral orchiectomy was performed. After his full recovery from an in-hospital infection by Acinetobacter baumannii, the patient was transferred to the plastic surgery department. The prompt surgical debridement has likely counterbalanced the health risk originated from COVID-19 infection, contributing to the patient’s full recovery. Testicular ischemia is a very rare condition in necrotizing fasciitis of the genital and perineal space and it could be attributed primarily to the thrombotic nature of coronavirus. Due to the assault of multiple organs and systems, a medical board consisting of urologists and other medical specialties substantially contributed to the favorable outcome.


  • Open Access

    Current Trends in Metabolic Evaluation of Patients with Urinary Tract Lithiasis

    by Anastasios Zarkadas, Dimitrios Bozios, Vassileios Konstantinopoulos, Eleftherios Tsiakoulias, Konstantinos Safioleas, Athanasios Filios, Evaggelos Rodinos, Despoina Mitiliniou, Georgios Kallinikas, Panagiots Filios, et al.

    Urolithiasis is one of the most frequent disorders of the urinary tract with a high prevalence among the general population. The etiology is multifactorial and is related primarily with, race, age, gender, occupation, hygienic-dietetic issues, lifestyle factors, geographic and climatic aspects, hereditariness, and metabolic changes. Therefore, for prevention of the disease, the metabolic causes responsible for stone formation should be addressed before and particularly after treatment. Key point for the metabolic evaluation is to perform stone analysis and to classify patients into low- and high-risk group. In low-risk patients, basic metabolic evaluation is proposed comprising basic urine and blood tests. Spot urinalysis should include red cells, white blood cells, nitrite, urine pH, urine microscopy, and culture if indicated. Basic blood testing includes blood cell count, creatinine, uric acid, ionized calcium, sodium, potassium, and C-reactive protein if indicated. In high-risk stone formers, apart from the basic workup, analysis of two 24-h urine samples should be examined for evaluation of the total urine volume as well as the concentration of creatinine, calcium, phosphate, oxalate, urea nitrogen, uric acid, citrate, magnesium, sodium, and if indicated of cystine. Further examination should be based on the composition of stone. The follow-up of stone formers is still matter of debate, but most experts agree that the follow-up should be individualized according to stones composition, the underlying metabolic cause, and the treatment that has been offered.

  • Prognostic factors for the safety and efficacy of retrograde laser lithotripsy: Data from a contemporary series of 155 consecutive patients with single and multiple lithiasis of the urinary tract

    by Diomidis Kozyrakis, Georgios Soukias, Dimitrios Karagiannis, Anastasios Zarkadas, Stefanos Perikleous, Styliani-Elissavet Chatzistamou, Ilias Katsaros, Konstantinos Skriapas, Michael Lardas, Nikolaos Mertziotis, et al.

    Treatment of large and multiple stones located in the ureter and/or the kidney may be challenging. The aim of the current study was to evaluate the results and complications of retrograde endoscopic lithotripsy for stones located in the urinary tract and to determine prognostic factors for treatment outcome. From April 2017 to March 2020, eligible patients for the active treatment of ureterolithiasis with or without concomitant nephrolithiasis <20 mm were enrolled in the study. The prognostic factors for the stone free rate (SFR) after the 1st and subsequent sessions and overall complications were assessed. Patients were divided into single or multiple lithiasis groups (groups A and B respectively). A comparison between these two groups was then conducted. Overall, 237 stones were detected in 155 patients, representing a mean burden of 1.53 stone per patient. The mean total stone size was 14.7 mm, the initial SFR was 80% and the final SFR (after a mean of 1.23 session per patient) was 94.2%. The rate of complications was 26.4%. Multivariative analysis revealed that preoperative stenting and total stone size were independent prognostic factors of initial SFR, while no independent factors were determined for final SFR. Age, total size and stones in the lower calyx were independent factors for complications. In group A and B, 114 and 41 cases with solitary and multiple stones were included, respectively. Excluding operation time (P=0.002), no significant differences were recorded in terms of initial (P=0.255) and final SFR (P=0.056), hospital stay (P=0.308), mean number of treatments (P=0.757) and the rate of complications (P=0.218) between the two groups. In conclusion, retrograde endoscopic management of multiple lithiasis has a favorable outcome irrespective of stone location. Older patients with higher burdens and stones in the lower calyx should be treated with caution.


  • Open Access

    Feasibility of a single session retrograde endoscopic laser lithotripsy of two large stones located in a bifid urinary tract. Presentation of a rare case

    by Diomidis Kozyrakis, Anastasios Zarkadas, Ilias Katsaros, Vasileios Mourkas, Zisis Kratiras

    A 76 year-old male presented with urosepsis and acute renal injury secondary to obstruction by a 13 mm stone located in the common segment of a bifid left ureter. A second 10 mm stone was detected in the mid calyx of the lower moiety of the kidney. Drainage of both moieties with two double-J stents was initially performed. Following recovery from urosepsis a retrograde endoscopic semirigid and flexible laser lithotripsy of the distal and proximal stone respectively was performed resulting in stone clearance. Although retrograde ureterolithotripsy has been presented in the past, to the best of the authors’ knowledge, this is the first description of flexible retrograde intrarenal lithotripsy performed through a bifid ureter.